EFFECTS OF PERINDOPRIL TREATMENT ON PLASMA AND URINE OF KALLIKREIN ACTIVITY AND THE STABLE METABOLITE OF PROSTAGLANDIN E(2) IN PATIENTS WITH ESSENTIAL-HYPERTENSION
S. Zacharieva et al., EFFECTS OF PERINDOPRIL TREATMENT ON PLASMA AND URINE OF KALLIKREIN ACTIVITY AND THE STABLE METABOLITE OF PROSTAGLANDIN E(2) IN PATIENTS WITH ESSENTIAL-HYPERTENSION, Methods and findings in experimental and clinical pharmacology, 18(3), 1996, pp. 205-209
Eleven male patients with essential hypertension were included in the
study. They followed an unrestricted diet and received a single oral d
aily doe of 4 mg perindopril (ACE inhibitor) for 6 weeks. Plasma renin
activity increased significantly and plasma aldosterone decreased sig
nificantly after perindopril treatment, suggesting than effective bloc
kade of angiotensin II formation was accomplished. Both systolic and d
iastolic blood pressure decreased. Urinary bicycloprostaglandin E(2) (
an inactive metabolite of prostaglandin E(2)) increased significantly,
while plasma and urinary kallikrein activity decreased significantly
ater perindopril treatment. The results obtained demonstrated signific
ant changes in prostaglandin E(2) and kallikrein activity during ACE i
nhibition. The contributive role of these humoral factors in the hypot
ensive effect of perindopril are discussed.